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CASE REPORT
A 22-year old female patient was referred to the Oral Medicine 
Clinic from the Haematology Ward at Groote Schuur Hospital 
for evaluation of a painful oral ulcer, which had been present for 
three weeks. The patient reported that, six weeks ago, she had 
sought treatment from her own dentist for painful and bleed-
ing gingivae. The dentist performed a scale and polish and 
prescribed a combination of amoxicillin and metronidazole, at 
normal adult doses, for seven days. The gingival bleeding had 
not resolved by the time she presented for her recall visit, two 
weeks later. The patient also reported the presence of “small, 
purple spots” on her lower limbs and trunk.
On the basis of the poor response to treatment and the pres-
ence of petechial haemorrhage, the attending dentist referred 
her to the Haematology Department at Groote Schuur Hospi-
tal for further investigation and management.
On arrival at the Oral Medicine Clinic, the patient presented 
her laboratory results which revealed pancytopenia with very 
low values for red blood cells (anaemia), white blood cells 
(leukopenia) and platelets (thrombocytopenia). The referral 
note from Haematology stated that a diagnosis had been 
reached of aplastic anaemia of unknown etiology. Intra-oral 
examination revealed the presence of a crateriform ulcer on 
the right palatal fauces, measuring approximately 2cm in 
diameter. The margins were erythematous with a pale yel-
low centre (Figure 1). Marginal gingivitis was present around 
several teeth and in addition, tooth 36 showed the presence 
of punched-out gingival papillae on the lingual side. Plaque 
and calculus deposits were present on the lingual surfaces 
of the anterior mandibular teeth.
Consultation with the referring haematologist revealed that 
management of the patient’s aplastic anemia would entail 
either a transplant (bone marrow and blood) or, should no 
donor be available, anti-thymocyte globulin treatment. At the 
time of the initial consultation, the required medication was 
still awaited and the patient was being managed by regular 
platelet administration. 
A scaling and polishing was performed on the same day the 
patient received platelets. A doxycycline mouth-rinse was 
prescribed, to be used twice daily, for one week. The patient 
presented for a follow-up visit two weeks later and by this 
time, the original gingival inflammation and ulceration had 
completely resolved (Figure 2). However, a new painful ulcer, 
of approximately 0.2cm in diameter, had developed on the 
right margin of the tongue, close to the tip. The ulcer had a 
red border with a whitish-yellow base (Figure 3). It was de-
cided that the lesion be monitored and further consultation 
with the attending haematologist sought, should the lesion 
persist and a biopsy be required. In the interim, the patient 
was requested to maintain good plaque control and to use 
a 0.2% chlorhexidine gluconate mouth rinse, twice daily and 
to return should further oral problems arise.
DISCUSSIOn
Aplastic anaemia is a relatively uncommon condition oc-
curing mostly in the teens and twenties, but also among 
the elderly. It was first described by Elrich in 18881 and is 
a condition in which multi-potential myeloid stem cells are 
suppressed, leading to hypo-cellularity of the bone marrow 
and resulting in a pancytopenia, with a deficiency of erythro-
cytes, granulocytes and platelets.2 A pancytopenia is diag-
nosed when two of three criteria are met: a neutrophil count 
of less than 0.5 x 109 cells/L, a platelet count less than 20 x 
109 cells/L and a reticulocyte count less than 1%. When the 
neutrophil count is less than 0.2 x109, the disease is then 
characterised as severe.2 
A plastic anaemia is classified as acquired or congenital. The 
congenital type is rare and usually associated with Fanconi’s 
anaemia and dyskeratosis congenita.3 In more than 50% of 
the acquired cases of aplastic anaemia, the cause is un-
known. In some cases, exposure to myelotoxic agents, such 
as drugs or chemicals, or a viral infection such as Hepatitis 
C virus and infectious mononucleosis, are implicated.2,4 Al-
though aplastic anaemia has traditionally been associated 
with exposure to various drugs and chemicals, the risk is 
relatively minor, considering the large number of people us-
ing such drugs. Drugs that have been implicated are various 
non-steroidal anti-inflammatory drugs, antibiotics (especially 
sulphonomides), anti-thyroid drugs, cardiovascular drugs, 
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corticosteroids, penicillamine and allopurinol. The major-
ity of cases of aplastic anaemia, however, are considered 
to have an immune pathophysiology. T-lymphocytes are 
thought to be responsible for the haemotopoetic cell de-
struction and although external exposures, (viruses, drugs, 
toxins), may trigger the aberrant immune response in some 
cases, the nature of the antigen responsible for driving this 
T-lymphocytic response remains uncertain in the majority 
of patients.5,6 
Definitive diagnosis of aplastic anaemia requires bone mar-
row aspirate smears, or core biopsy specimens. This shows a 
strikingly fatty bone marrow, indicating aplasia, however, this 
hypo-cellularity may also be found in other haematological 
diseases, such as clonal diseases (including myelodyspla-
sia) and single haematopoeitic lineage deficiency diseases 
(agranulocytosis, pure red cell aplasia, amegarakaryocytic 
thrombocytopenia).5 The clinical features of aplastic anemia 
are associated with the pancytopenia. Anaemia results in 
weakness, fatigue and pallor. Thrombocytopenia results in 
gingival bleeding, epistaxis, menorrhagia and purpura and 
the neutropenia results in increased susceptibility to infec-
tion and sepsis.1,7 Sepsis and haemorrhage are implicated 
as the main cause of death in such patients.7 
Oral manifestations are common in patients with aplastic 
anaemia and are directly associated with the pancytope-
nia. These manifestations include petechial haemorrhages, 
gingival swelling and spontaneous bleeding, ulceration, pal-
lor and severe periodontal disease.3,4 Cases of advanced 
or rapidly progressive periodontitis have been reported to 
occur with prolonged neutropenia and may be due to sev-
eral qualitative and quantitative neutrophil defects, includ-
ing neutropenia, agranulocytosis and leukocyte adhesion 
deficiency.3 In addition, the thrombocytopenia can induce 
compromised clotting, so surgical intervention should be 
delayed until the patient is controlled with platelet adminis-
tration.3 Brennan4 describes the risk factors associated with 
oral manifestations of aplastic anaemia and suggests that 
the level of thrombocytopenia is not necessarily indicative of 
the degree of petechial haemorrhaging. These lesions most 
likely result from the thrombocytopenia-induced clotting dis-
order, which causes excessive bleeding even after minor 
trauma associated with normal oral functioning. 
Treatment of aplastic anaemia is directed at suppression 
of the immune system, or in more severe cases, a bone 
marrow transplant. The bone marrow transplant aims to 
replace the bone marrow cells with new multi-potential 
stem cells from a matching donor. This may effect a cure 
in 70% of cases and even higher in younger patients with 
a matching sibling donor. Graft rejection and graft-versus-
host disease remain serious risks, but can be contained 
by careful patient management.2,5 The immune-modulating 
treatment is based on a short course of anti-thymocyte 
globulin or anti-lymphocyte globulin and several months on 
cyclosporin to modulate the patient’s immune response.2 
Cyclosporine, however, may enhance the gingival swelling 
and bleeding and thus may be of special concern to the 
oral health care practitioner.4 Chemotherapy with agents 
such as cyclophosphamide and vincristine may also be 
effective, but these agents can enhance the neutropenia, 
so severe infections remain a serious risk.5 The prognosis 
of the immune-modulating treatment is relatively high, with 
5-year survival rates of up to 75%.6
COnCLUSIOnS
The present case is a stark reminder that oral health care 
practitioners should always be on the alert for cases of 
aplastic anaemia. Any signs of excessive bleeding, or a 
poor response to the standard treatment of infections and 
oral ulcerations, should be investigated to rule out a pos-
sible presence of pancytopenia. The initial attending den-
tist in the present case, was astute in recognising the lack 
of response in the patient and to associate this with the 
presence of petechial haemorrhage. His early referral of 
the patient for specialised care will undoubtedly be of con-
siderable value to the patient in the management of this 
potentially fatal disease.
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Figure 1: The patient presented with a painful chron-
ic ulcer on the right palatal fauces and with gingivitis 
around the right lower molar teeth.
Figure 3: At follow up visit a new painful ulcer of 
0.2cm in size was present on the right margin of the 
tongue, close to the tip.
Figure 2: At the time of the follow up visit, two weeks 
later, the ulcer and gingivitis had fully resolved.
